Expression of sialyltransferase family members in cervix squamous cell carcinoma correlates with lymph node

Related Experiment Videos

Peng-Hui Wang1, Ywan Feng Li, Chi-Mou Juang

  • 1Department of Obstetrics and Gynecology, Taipei Veterans General Hospital and Institute of Clinical Medicine, Taiwan.

Gynecologic Oncology
|June 25, 2002
PubMed
Abstract

Insights

Increased expression of sialyltransferases ST3Gal III and ST6Gal I in cervical cancer is linked to lymph node metastasis. ST6Gal I overexpression is particularly relevant for poor prognostic factors in FIGO stage IB1 disease.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Altered messenger ribonucleic acid (mRNA) expression of sialyltransferases (STs) is implicated in cervical squamous cell carcinoma.
  • Specific STs include ST3Gal I, ST3Gal III, ST3Gal IV, and ST6Gal I.

Purpose of the Study:

  • To investigate changes in mRNA expression of four STs in FIGO stage IB1 cervical squamous cell carcinoma.
  • To assess the extent of sialylation associated with lymph node metastases.

Main Methods:

  • Semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to examine ST mRNA expression.
  • Study included 79 patients with FIGO IB1 cervical squamous cell carcinomas.

Main Results:

  • ST6Gal I and ST3Gal III mRNA expressions were significantly increased in patients with lymph node metastases.
  • ST3Gal III and ST6Gal I demonstrated high accuracy in predicting lymph node metastases (AUCs of 0.810 and 0.786, respectively).
  • High ST6Gal I expression correlated with deep stromal invasion, lymph-vascular space involvement, and larger tumor size.

Conclusions:

  • ST3Gal III and ST6Gal I are important in lymph node metastasis for FIGO IB1 cervical cancer.
  • Overexpression of ST6Gal I is crucial for poor prognostic factors including deep stromal invasion, lymph-vascular space involvement, and lymph node metastasis.

Related Concept Videos